News | Heart Valve Technology | June 19, 2020

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts

TAVR is quickly becoming the preferred option for majority of the heart valve patients in India

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts. The company's Hydra TAVR (TAVI) valve gained European CE mark clearance in June 2020.

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device firm Vascular Concepts. The acquisition was completed May 27. 

The company recently gained European CE mark for its Hydra transcatheter aortic valve implantation (TAVI) system in early June 2020.

Vascular Concept will retain its distinct brand and independence and Swaminathan Jayaraman, CEO of Vascular Concept, will continue to manage the operation of the company.

The company has operations in India and Thailand and has more than 200 employees, with two manufacturing sites and two research and development centers. 

It is one of the oldest Indian medical device companies, established in 1988. It has a diversified product portfolio which includes coronary stents, cardiac closure devices, peripheral stents, unique balloon catheters like percutaneous transvenous mitral commissurotomy (PTMC) balloons and transcatheter aortic valve replacement (TAVR) devices.

Vascular Concept developed and launched the Hydra transcatheter aortic valve system, which received Indian regulatory approval in 2020. It is used for the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis. The Hydra TAVR system is a self-expanding supra-annular transcatheter aortic valve, which presents unique design features and similar event rates compared to contemporary devices in separate clinical studies conducted in India and Europe. The TAVI market is growing at about 20% worldwide, Europe and the U.S. being the main markets to date.

“The structural heart segment is a fast-growing segment in cardiovascular industry. We strongly believe that SMT will play a major role within this segment and provide solutions to benefit patients and its wide customer base," explained Dhirajlal Kotadia, chairman of SMT. "Acquisition of Vascular Concepts Group reflects our commitment to become a leader in TAVI and structural heart technologies.”

“We are excited to join hands with SMT, who have a strong leadership in interventional cardiology and has demonstrated aggressive growth in this business," said Jayaraman. "This association will create tremendous market opportunities for both companies to grow in structural heart disease. Vascular Concepts is committed to driving further innovation in the field of structural heart, which can be commercialized together with SMT.”

With an addition of aortic valve to its product categories, SMT advances in its mission to provide best-in-class cardiac care to the healthcare community and patients. 

 

Related SMT Cardiology Device Content:

SMT Hydra TAVR System Receives European CE Mark Approval 

Innovations in Cardiovascular Disease Treatment and the Rising Demand for Stents 

Supraflex Drug-Eluting Stent Superior to Xience in Two-Year Target Vessel Failure

Coronary Stent Market Characterized by New Drug-eluting Stents
 

Related Content

News | Cardiovascular Business

August 17, 2022 — Memorial Healthcare System, a South Florida-based academic medical center, has added a diverse trio of ...

Home August 17, 2022
Home
News | Cardiovascular Business

August 16, 2022 — A study of cardiology programs indicates that patients’ documented do-not-resuscitate (DNR) ...

Home August 16, 2022
Home
News | Cardiovascular Business

August 16, 2022 — Two leaders in cardiovascular disease science, research and education, the American Heart Association ...

Home August 16, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Diagnostic and Interventional Cardiology (DAIC) maintains more than 30 comparison charts of product specifications from ...

Home August 12, 2022
Home
News | Cardiovascular Business

August 12, 2022 — Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, announced ...

Home August 12, 2022
Home
News | Cardiovascular Business

August 10, 2022 — On July 27, ASNC joined a coalition of more than 100 medical societies urging Congress to pass ...

Home August 10, 2022
Home
News | Cardiovascular Business

August 5, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 05, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

Home August 01, 2022
Home
News | Cardiovascular Business

July 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias ...

Home July 22, 2022
Home
News | Cardiovascular Business

July 19, 2022 — On July 7, the Centers for Medicare & Medicaid Services (CMS) released the 2023 Medicare Physician Fee ...

Home July 19, 2022
Home
Subscribe Now